Best of Community Cancer Care Workshop - March 8, 2023
Community practitioners have reported that an overwhelming amount of clinical information available for cancer therapies was a significant acute and chronic knowledge and competency gap and reiterated the need for additional education on new classes of drugs, updated clinical practice guidelines, side effect management, supportive care services, quality improvement strategies, and optimizing healthcare delivery. Community clinicians often cannot travel to large national conferences, warranting the need for local and regional programs to educate them on the most recent clinical data presented.
Oncology physicians, oncology nurses, oncology pharmacists, cancer program and practice directors/ managers/ administrators, hospital executives, patient navigators, financial advocates, and social workers.
- Review highlights of the advances in clinical and translational research presented at recent national clinical conferences
- Provide opportunities for discussion with leading oncology experts on translation of new investigational clinical and operational updates into patient care strategies
- Establish collaborations between community oncology clinicians and cancer program administrators to address challenges of integrating new data into practice
- Evaluate tools and resources in specific areas of cancer management that can be used to achieve effective cancer care delivery and improve the patient experience
CME Operations Manager: Naomi Moller
In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and the Association of Community Cancer Centers. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Contact Hours: 3.0, of which 3.0 are eligible for pharmacology credit
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an application-based educational activity. Pharmacists will receive 3.0 contact hours (0.3 CEUS) for the educational activity. No partial credit is available.
UNIVERSAL ACTIVITY NUMBER (UAN) 0060-9999-22-082-L01-P
- 3.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 3.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 3.00 ANCC
- 1.00 ANCC Pharmacology
- 3.00 Participation